Center-Authored Papers

Filters: Author is Warren, Edus H  [Clear All Filters]
2008
Tykodi SS, Fujii N, Vigneron N, Lu SM, Mito JK, Miranda MX, Chou J, Voong LN, Thompson JA, Sandmaier BM et al..  2008.  C19orf48 encodes a minor histocompatibility antigen recognized by CD8+ cytotoxic T cells from renal cell carcinoma patients.. Clinical cancer research : an official journal of the American Association for Cancer Research. 14(16):5260-9. Abstract
Flowers MED, Storer BE, Carpenter PA, Rezvani AR, Vigorito AC, Campregher PV, Moravec C, Kiem H-P, Fero ML, Georges GE et al..  2008.  Treatment change as a predictor of outcome among patients with classic chronic graft-versus-host disease.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 14(12):1380-4. Abstract
Rosinski KV, Fujii N, Mito JK, Koo KKW, Xuereb SM, Sala-Torra O, Gibbs JS, Radich JP, Akatsuka Y, Van den Eynde BJ et al..  2008.  DDX3Y encodes a class I MHC-restricted H-Y antigen that is expressed in leukemic stem cells.. Blood. 111(9):4817-26. Abstract
2009
McCarroll SA, Bradner JE, Turpeinen H, Volin L, Martin PJ, Chilewski SD, Antin JH, Lee SJ, Ruutu T, Storer BE et al..  2009.  Donor-recipient mismatch for common gene deletion polymorphisms in graft-versus-host disease.. Nature genetics. 41(12):1341-4. Abstract
Chien JW, Zhao LP, Storer BE, Martin PJ, Boeckh MJ, Warren EH, Hansen JA.  2009.  Improving hematopoietic cell transplant outcomes in a new era of genomic research.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 15(1 Suppl):42-5.
Spellman S, Warden MB, Haagenson M, Pietz BC, Goulmy E, Warren EH, Wang T, Ellis TM.  2009.  Effects of mismatching for minor histocompatibility antigens on clinical outcomes in HLA-matched, unrelated hematopoietic stem cell transplants.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 15(7):856-63. Abstract
Nishida T, Hudecek M, Kostic A, Bleakley M, Warren EH, Maloney DG, Storb R, Riddell SR.  2009.  Development of tumor-reactive T cells after nonmyeloablative allogeneic hematopoietic stem cell transplant for chronic lymphocytic leukemia.. Clinical cancer research : an official journal of the American Association for Cancer Research. 15(14):4759-68. Abstract
Vigorito AC, Campregher PV, Storer BE, Carpenter PA, Moravec CK, Kiem H-P, Fero ML, Warren EH, Lee SJ, Appelbaum FR et al..  2009.  Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD.. Blood. 114(3):702-8. Abstract
Robins HS, Campregher PV, Srivastava SK, Wacher A, Turtle CJ, Kahsai O, Riddell SR, Warren EH, Carlson CS.  2009.  Comprehensive assessment of T-cell receptor beta-chain diversity in alphabeta T cells.. Blood. 114(19):4099-107. Abstract
Warren EH.  2009.  Genetic risk for colitis-associated colorectal cancer.. Gut. 58(9):1177-9.
2010
Bleakley M, Otterud BE, Richardt JL, Mollerup AD, Hudecek M, Nishida T, Chaney CN, Warren EH, Leppert MF, Riddell SR.  2010.  Leukemia-associated minor histocompatibility antigen discovery using T-cell clones isolated by in vitro stimulation of naive CD8+ T cells.. Blood. 115(23):4923-33. Abstract
Campregher PV, Srivastava SK, Deeg HJ, Robins HS, Warren EH.  2010.  Abnormalities of the alphabeta T-cell receptor repertoire in advanced myelodysplastic syndrome.. Experimental hematology. 38(3):202-12. Abstract
Miller JS, Warren EH, van den Brink MRM, Ritz J, Shlomchik WD, Murphy WJ, Barrett JA, Kolb HJ, Giralt S, Bishop MR et al..  2010.  NCI First International Workshop on The Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic HSCT: . Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 16(5):565-86. Abstract
Warren EH, Fujii N, Akatsuka Y, Chaney CN, Mito JK, Loeb KR, Gooley TA, Brown ML, Koo KKW, Rosinski KV et al..  2010.  Therapy of relapsed leukemia after allogeneic hematopoietic cell transplantation with T cells specific for minor histocompatibility antigens.. Blood. 115(19):3869-78. Abstract
Hansen JA, Chien JW, Warren EH, Zhao LP, Martin PJ.  2010.  Defining genetic risk for graft-versus-host disease and mortality following allogeneic hematopoietic stem cell transplantation.. Current opinion in hematology. 17(6):483-92. Abstract
Robins HS, Srivastava SK, Campregher PV, Turtle CJ, Andriesen J, Riddell SR, Carlson CS, Warren EH.  2010.  Overlap and effective size of the human CD8+ T cell receptor repertoire.. Science translational medicine. 2(47):47ra64. Abstract
2011
Grogan BM, Tabellini L, Storer BE, Bumgarner TE, Astigarraga CC, Flowers MED, Lee SJ, Martin PJ, Warren EH, Hansen JA.  2011.  Activation and expansion of CD8(+) T effector cells in patients with chronic graft-versus-host disease.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(8):1121-32. Abstract
Falkenburg FJH, Warren EH.  2011.  Graft versus leukemia reactivity after allogeneic stem cell transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(1 Suppl):S33-8.
Inamoto Y, Flowers MED, Lee SJ, Carpenter PA, Warren EH, Deeg HJ, Storb R, Appelbaum FR, Storer BE, Martin PJ.  2011.  Influence of immunosuppressive treatment on risk of recurrent malignancy after allogeneic hematopoietic cell transplantation.. Blood. 118(2):456-63. Abstract
Eissa H, Gooley TA, Sorror ML, Nguyen F, Scott BL, Doney K, Loeb KR, Martin PJ, Pagel JM, Radich JP et al..  2011.  Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia: relapse-free survival is determined by karyotype and comorbidities.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(6):908-15. Abstract
Tykodi SS, Sandmaier BM, Warren EH, Thompson JA.  2011.  Allogeneic hematopoietic cell transplantation for renal cell carcinoma: ten years after.. Expert opinion on biological therapy. 11(6):763-73. Abstract
Flowers MED, Inamoto Y, Carpenter PA, Lee SJ, Kiem H-P, Petersdorf EW, Pereira S, Nash RA, Mielcarek M, Fero ML et al..  2011.  Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria.. Blood. 117(11):3214-9. Abstract
Warren EH.  2011.  Blazing a trail in T-cell recognition.. Blood. 117(18):4681-2.
Inamoto Y, Fefer A, Sandmaier BM, Gooley TA, Warren EH, Petersdorf SH, Sanders JE, Storb R, Appelbaum FR, Martin PJ et al..  2011.  A Phase I/II Study of Chemotherapy Followed by Donor Lymphocyte Infusion plus Interleukin-2 for Relapsed Acute Leukemia after Allogeneic Hematopoietic Cell Transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(9):1308-15. Abstract
2012
Chou J, Voong LN, Mortales CL, Towlerton AMH, Pollack SM, Chen X, Yee C, Robbins PF, Warren EH.  2012.  Epigenetic Modulation to Enable Antigen-specific T-cell Therapy of Colorectal Cancer.. Journal of immunotherapy (Hagerstown, Md. : 1997). 35(2):131-41. Abstract